Mark W. Begor - 09 Feb 2024 Form 4 Insider Report for EQUIFAX INC (EFX)

Role: CEO, Director
Signature: /s/Lisa Stockard as Attorney-in-Fact
Issuer symbol: EFX
Transactions as of: 09 Feb 2024
Net transactions value: $0
Form type: 4
Filing time: 13 Feb 2024, 16:10:10 UTC
Previous filing: 02 Nov 2023
Next filing: 14 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EFX	Common Stock	Award	$0	+8,107	+13%	$0.000000	71,204	09 Feb 2024	Direct	F1, F2
holding	EFX	Common Stock						20,025	09 Feb 2024	2-Year 2022 GRAT
holding	EFX	Common Stock						69,360	09 Feb 2024	2-Year 2023 GRAT
holding	EFX	Common Stock						13,475	09 Feb 2024	2-year May 2022 GRAT
holding	EFX	Common Stock						23,083	09 Feb 2024	4-Year 2021 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EFX	Stock Option/Right to Buy	Award	$0	+15,662		$0.000000	15,662	09 Feb 2024	Common Stock	15,662	$299.02	Direct	F3
transaction	EFX	Stock Option/Right to Buy	Award	$0	+14,097		$0.000000	14,097	09 Feb 2024	Common Stock	14,097	$274.10	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 9, 2027.
F2	Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3	Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 9, 2025.